Literature DB >> 3834754

Augmented chemoreceptor reflex tonic drive in early human hypertension and in normotensive subjects with family background of hypertension.

M Tafil-Klawe, A Trzebski, J Klawe, T Pałko.   

Abstract

The study was carried out in 30 subjects with mild primary hypertension and in 82 normotensive age-matched volunteers, 18-20 years of age. Hyperoxia test was used to withdraw the tonic chemoreceptor reflex drive. The following circulatory and respiratory effects of short lasting hyperoxia were observed in the hypertensive group and in most of the normotensive subjects yet with a family background of hypertension: a decrease in the mean arterial pressure, in total peripheral vascular resistance, and in forearm vascular resistance, and a significantly greater reduction of the resting ventilation as compared to the normotensive group. Our results suggest that the augmented arterial chemoreceptor drive is one of the mechanisms responsible for the elevated arterial blood pressure and total peripheral resistance in early human hypertension. The positive response to hyperoxia test in healthy subjects with a family background of hypertension suggests a familial occurrence of the hyperactivity of the arterial chemoreceptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834754

Source DB:  PubMed          Journal:  Acta Physiol Pol        ISSN: 0044-6033


  12 in total

1.  Obesity, Hypoxemia, and Hypertension: Mechanistic Insights and Therapeutic Implications.

Authors:  Allyn L Mark; Virend K Somers
Journal:  Hypertension       Date:  2016-05-09       Impact factor: 10.190

2.  CT angiography in the detection of carotid body enlargement in patients with hypertension and heart failure.

Authors:  Sreejit Nair; Ajay Gupta; Marat Fudim; Christopher Robinson; Vinay Ravi; Sandra Hurtado-Rua; Zoar Engelman; Kyungmouk S Lee; C Douglas Phillips; Akhilesh K Sista
Journal:  Neuroradiology       Date:  2013-09-05       Impact factor: 2.804

Review 3.  Regulation of breathing and autonomic outflows by chemoreceptors.

Authors:  Patrice G Guyenet
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

4.  The need for specificity in quantifying neurocirculatory vs. respiratory effects of eucapnic hypoxia and transient hyperoxia.

Authors:  Bharati Prasad; Barbara J Morgan; Ahana Gupta; David F Pegelow; Mihaela Teodorescu; John M Dopp; Jerome A Dempsey
Journal:  J Physiol       Date:  2020-08-25       Impact factor: 5.182

5.  Hypertension is critically dependent on the carotid body input in the spontaneously hypertensive rat.

Authors:  Ana P Abdala; Fiona D McBryde; Nephtali Marina; Emma B Hendy; Zoar J Engelman; Marat Fudim; Paul A Sobotka; Alexander V Gourine; Julian F R Paton
Journal:  J Physiol       Date:  2012-06-11       Impact factor: 5.182

Review 6.  Carotid body overactivity induces respiratory neurone channelopathy contributing to neurogenic hypertension.

Authors:  Davi J A Moraes; Benedito H Machado; Julian F R Paton
Journal:  J Physiol       Date:  2015-05-20       Impact factor: 5.182

Review 7.  Revelations about carotid body function through its pathological role in resistant hypertension.

Authors:  Julian F R Paton; Laura Ratcliffe; Dagmara Hering; Jacek Wolf; Paul A Sobotka; Krzysztof Narkiewicz
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

8.  Cooperative Oxygen Sensing by the Kidney and Carotid Body in Blood Pressure Control.

Authors:  Daniela Patinha; Wioletta Pijacka; Julian F R Paton; Maarten P Koeners
Journal:  Front Physiol       Date:  2017-10-04       Impact factor: 4.566

Review 9.  Orexin, cardio-respiratory function, and hypertension.

Authors:  Aihua Li; Eugene Nattie
Journal:  Front Neurosci       Date:  2014-02-12       Impact factor: 4.677

10.  The effect of hyperoxia on central blood pressure in healthy subjects.

Authors:  Maciej Siński; Jacek Lewandowski; Anna Dobosiewicz; Jacek Przybylski; Piotr Abramczyk; Zbigniew Gaciong
Journal:  Arch Med Sci       Date:  2016-08-24       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.